We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App




Mindray Launches High Throughput BS-600M Chemistry Analyzer with Industry-Leading Small Footprint

By LabMedica International staff writers
Posted on 16 May 2022
Print article
Image: The new BS-600M chemistry analyzer provides a complete package to help labs grow (Photo courtesy of Mindray)
Image: The new BS-600M chemistry analyzer provides a complete package to help labs grow (Photo courtesy of Mindray)

Mindray (Shenzhen, China) has launched the new BS-600M, a powerful yet efficient chemistry analyzer designed to empower medium-volume laboratories with increased productivity, efficiency and reliability.

With a compact footprint of only 1.2 square meters and a throughput of 600 T/H (up to 800 T/H with ISE), the BS-600M chemistry analyzer has among the highest levels of throughput per square meter. It maximizes productivity for laboratories in a minimum amount of space. BS-600M allows continuous sample loading by racks and flexible STAT priority, which enables higher efficiency and prolonged walk-away time. Having high Sigma metric performance, it can help laboratories deliver high levels of testing quality, reduce QC measurements, simplify QC rules, and shorten turn-around time. These advantages enable significant reductions in troubleshooting work and consumption of QCs and reagents.

BS-600M features on-board hemolysis with whole blood for HbA1c tests. This eliminates the need for manual pretreatment, improving testing efficiency and reducing biohazardous risks and human errors. Mindray’s HbA1c assay on BS-600M can achieve excellent accuracy and precision. The enzymatic HbA1c method can also effectively prevent interferences from Hb variants and ensure no interference from other Hb derivatives. This means that reliable results can be obtained at the first measurement, without requiring further confirmations. Additionally, BS-600M requires much reduced reaction volumes for HbA1c tests, which contributes to around 30% lower cost per test. BS-600M also integrates a brand-new ISE solution, which reduces both the frequency of electrode replacement and the consumption of ISE reagents. As the result, the cost per test for ISE is reduced by around 35%. Moreover, ISE tests on BS-600M exhibit top levels of accuracy and precision in the field of ISE detection.

BS-600M also incorporates several other powerful functions, including intelligent detection, alarming and auto-rerun of abnormal reactions, fast input of QC & CAL target values via barcode scanning, a user-friendly operation interface, and breathing LEDs that indicate the status of the analyzer. All these powerful functions allow BS-600M to help medium-sized laboratories maximize their working efficiency and cost efficiency, and provide an amazing user experience for laboratory technicians. The performance advantages of BS-600M allow it to offer highly reliable results at reduced costs and to enhance clinician confidence and satisfaction.

Related Links:
Mindray 

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Pipet Controller
Stripettor Pro

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.